Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CDC42 inhibitors(Cell division control protein 42 homolog inhibitors), RAC1 inhibitors(Rac family small GTPase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Preclinical | Puerto Rico | 29 Apr 2025 | |
Prostatic Cancer | Preclinical | United States | 27 Apr 2025 | |
Breast Cancer | Preclinical | Puerto Rico | 08 Apr 2024 |